Body Dysmorphic Disorder (BDD) Marketed and Pipeline Drugs Assessment, Clinical Trials and Competitive Landscape
Summary
This reports provides a data-driven overview of the current and future competitive landscape in BDD therapeutics.
There will be 67,698,071 total prevalent cases of BDD in 2023 in the 16 countries covered in GlobalData’s epidemiology forecast.
No approved marketed drugs are currently available for the treatment of BDD.
R&D activity within the BDD space is negligible, with no pipeline products in late-stage clinical development.
Non-commercial sponsors currently dominate the BDD clinical development space.
No deals were implemented among companies developing BDD assets in the past 24 months.
Scope
GlobalData’s Body Dysmorphic Disorder (BDD) Marketed and Pipeline Drugs Assessment, Clinical Trials and Competitive Landscape combines data from the Pharma Intelligence Center with in-house analyst expertise to provide a competitive assessment of the disease marketplace.
Components of the report include -
Disease Landscape
Disease Overview
Epidemiology Overview
Treatment Overview
Marketed Products Assessment
Pricing and Reimbursement Assessment
Pipeline Assessment
Late-to-mid-stage Pipeline Drugs
Phase Transition Success Rate and Likelihood of Approval
Clinical Trials Assessment
Breakdown of Trials by Phase, Status, Virtual Components, Sponsors, Geography, and Endpoint Status
Enrolment Analytics, Site Analytics, Feasibility Analysis
Deals Landscape
Mergers, Acquisitions, and Strategic Alliances by Region
Overview of Recent Deals
Commercial Assessment
Key Market Players
Future Market Catalysts
Reasons to Buy
Develop and design your in-licensing and out-licensing strategies through a review of pipeline products and technologies, and by identifying the companies with the most robust pipeline.
Develop business strategies by understanding the trends shaping and driving the BDD market.
Drive revenues by understanding the key trends, innovative products and technologies, market segments, and companies likely to impact the global BDD market in the future.
Formulate effective sales and marketing strategies by understanding the competitive landscape and by analyzing the performance of various competitors.
Identify emerging players with potentially strong product portfolios and create effective counter-strategies to gain a competitive advantage.
Organize your sales and marketing efforts by identifying the market categories and segments that present maximum opportunities for consolidations, investments, and strategic partnerships.
Report Scope
Key Findings
Disease Overview
Epidemiology Overview
Epidemiology Overview: Total Prevalent Cases of BDD in 2023 and 2028
Treatment Overview
Treatment Guidelines
Management of BDD
Marketed Drugs Assessment
Marketed Drugs - Leading Marketed Drugs in BDD
Pricing and Reimbursement Assessment
Marketed Drugs - Annual Therapy Cost
Pipeline Drugs Assessment
Pipeline Drugs Overview - Pipeline Drugs in BDD
Pipeline Drugs - Phase Transition Success Rate and Likelihood of Approval in CNS Disorders
Clinical Trials Assessment
Clinical Trials in BDD - Historical Overview
Clinical Trials in BDD - Overview by Phase
Clinical Trials in BDD - Overview by Status
Clinical Trials in BDD - Overview by Phase for Ongoing and Planned Trials
Clinical Trials in BDD - Trials with a Virtual Component
Clinical Trials in BDD - Overview of Trials by Geography
Clinical Trials in BDD - Single-Country and Multinational Trials by Region
Clinical Trials in BDD - Top Sponsors with Breakdown by Phase
Clinical Trials in BDD - Top Sponsors with Breakdown by Status
Clinical Trials in BDD - Overview by Endpoint Status
Clinical Trials in BDD - Overview by Race and Ethnicity
Clinical Trials in BDD - Overview of Sites by Geography
Clinical Trials in BDD - Top Countries for Trial Sites
Clinical Trials in BDD - Top Sites Globally
Deals Landscape
Deals Landscape - Mergers, Acquisitions, and Strategic Alliances in BDD by Region
Commercial Assessment
Commercial Assessment - Key Market Players in BDD
Future Market Catalysts
Future Market Catalysts - Upcoming Market Catalysts in BDD
Appendix
Methodology
Methodology - Phase Transition Success Rate and Likelihood of Approval Analysis